The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry

In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in the Revised International Prognostic Scoring System (IPSS‐R)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Diamantopoulos, Panagiotis, Koumbi, Dafni, Kotsianidis, Ioannis, Pappa, Vasiliki, Symeonidis, Argiris, Galanopoulos, Athanasios, Zikos, Panagiotis, Papadaki, Helen A., Panayiotidis, Panayiotis, Dimou, Maria, Hatzimichael, Eleftheria, Vassilopoulos, George, Delimpasis, Susan, Mparmparousi, Despoina, Papageorgiou, Sotirios, Variami, Eleni, Kyrtsonis, Marie‐Christine, Megalakaki, Aekaterini, Kotsopoulou, Maria, Repousis, Panagiotis, Adamopoulos, Ioannis, Kontopidou, Flora, Christoulas, Dimitrios, Kourakli, Alexandra, Tsokanas, Dimitrios, Konstantinos Papoutselis, Menelaos, Kyriakakis, Georgios, Viniou, Nora‐Athina
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536924/
https://ncbi.nlm.nih.gov/pubmed/30897290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados